Financial Daily from THE HINDU group of publications
Tuesday, October 19, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

HOME PAGE

Govt to allow simultaneous clinical trials in India, abroad
"The decision to relax the norms was taken after it was found that a large portion of the clinical trials business has been moving to China, Indonesia and Thailand." More

Reliance Energy puts three power plants on the block
LEADING power producer and distributor Reliance Energy Ltd (REL) is selling its interests in three electricity generation plants that have a combined capacity of about 433 MW, it is learnt. REL has appointed a leading investment banker to ... More

Share transactions on Oct 12 — Affected investors in SSI move HC for redress
A GROUP of investors in SSI shares on Monday filed a writ petition in the Mumbai High Court seeking to annul/ reverse all transactions in the shares of the company that were traded on October 12 on the BSE and NSE. The investors have also ... More

LIC may bear service tax burden this year
THE Life Insurance Corporation (LIC) Chairman, Mr S.B. Mathur, on Monday indicated that the corporation's policyholders might not have to pay service tax during the current fiscal. ``It would be pretty difficult to pass on the service tax ... More

Tea exports increase; production declines in line with global trend
TEA exports from India are up. Domestic tea production is down in line with the global trend and the average price at auction houses is increasing. Nothing can be better for the tea industry. However, exports in August 2004 suffered a minor ... More

Oil cos tank under selling pressure
THE markets ended on a weak note on Monday, extending the loss that was witnessed on Friday. The BSE Sensex declined by 7 points or 0.12 per cent to close at 5679.83 points. The NSE Nifty saw a greater fall; the index declined 11 points or 0.50 ... More

Doubts over Cox-2 anti-inflammatory drugs loom large
IF you have been popping the painkiller and arthritis drug rofecoxib till it was recently withdrawn, do you have reasons to worry? If your doctor has replaced the locally produced version of rofecoxib in your prescription with another medicine ... More

N-E monsoon sets in over Tamil Nadu
Emerging consensus indicates a strong season this year. More




Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Pick a Winner Stock Market Contest

Top Stories
Review of duty on steel-making input likely


IRDA backs insurance FDI cap at 49%

Rs 5,000-cr gilts sale cancelled

TRAI explores sops for rural connectivity

Apparel exports up 16% in first half

US presidential debates — High point of American democracy

IPCL net climbs to Rs 138 cr in Q2


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line